HUMC 1612: Optune NovoTTF-200A System

Clinical trial NCT03128047 · COMPLETED

Trial details

NCT number: NCT03128047
Sponsor: Hackensack Meridian Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

High Grade Glioma Ependymoma

Start date: 2017-04-06
Primary completion: 2024-07-08
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.